Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02931552 · ClinicalTrials.gov registry record · NA
Nuevo Amanecer II: Translating a Stress Management Program for Latinas
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT02931552 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 153 participants.
The verdict
NCT02931552, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The primary aim is to assess the effectiveness of the Nuevo Amanecer-II (NA-II) cognitive-behavioral stress management program through a 6-month RCT with 150 Spanish-speaking Latinas with breast cancer in three rural settings in terms of improving quality of life (QoL) and reducing distress, compared to a usual care control group (that is offered the program at the end of the 6 months). The investigators will also test the effects of the program on biomarkers of stress (hair and saliva cortisol) and aging (telomere length from saliva). Trained Latinas, called Compañeras (Companions), who have had breast cancer deliver the stress management program in-person to Spanish-speaking Latinas with breast cancer.
Interventions
- BEHAVIORAL Nuevo Amancer-II Stress Management Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02931552
The ClinicalTrials.gov registry entry for NCT02931552 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nuevo Amancer-II Stress Management Program is the first listed.
NCT02931552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02931552 about?
NCT02931552 is a clinical study titled "Nuevo Amanecer II: Translating a Stress Management Program for Latinas". The primary aim is to assess the effectiveness of the Nuevo Amanecer-II (NA-II) cognitive-behavioral stress management program through a 6-month RCT with 150 Spanish-speaking Latinas with breast cancer in three rural settings in terms of improving quality of life (QoL) and reducing distress, compare...
What is the current status of trial NCT02931552?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2016-09. Estimated completion is 2019-02.
What interventions are being tested in trial NCT02931552?
The interventions under investigation include: Nuevo Amancer-II Stress Management Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02931552?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.